Back to Results
First PageMeta Content
Medicine / CD46 / Multiple myeloma / Paraprotein / Plasma cell / Anatomy / Biology / Hematologic neoplasms


Phase I trial of systemic administration of Edmonston strain of measles virus, genetically engineered to express NIS, with or without cyclophosphamide, in patients with recurrent or refractrory multiple myeloma Angela Di
Add to Reading List

Document Date: 2013-12-16 10:07:58


Open Document

File Size: 1,44 MB

Share Result on Facebook
UPDATE